Surgical treatment of mitral valve disease with severe mitral annular calcifications (MACs) is challenging, with reported high morbidity and mortality. Transcatheter treatment options are feasible, however, still far from being optimal alternatives. We report our positive experience with the off-label implant of a BioIntegral Injectable BioPulmonic valve fitted on a circumferential pericardial skirt for the treatment of severe MAC.
FoxCSVasanRSPariseH, et al.Mitral annular calcification predicts cardiovascular morbidity and mortality: the Framingham Heart Study. Circulation2003; 107: 1492–1496.
2.
FeindelCMTufailZDavidTE, et al.Mitral valve surgery in patients with extensive calcification of the mitral annulus. J Thorac Cardiovasc Surg2003; 126: 777–782.
3.
FusiniLGhulam AliSTamboriniG, et al.Prevalence of calcification of the mitral valve annulus in patients undergoing surgical repair of mitral valve prolapse. Am J Cardiol2014; 113: 1867–1873.
4.
GuerreroMDvirDHimbertD, et al.Transcatheter mitral valve replacement in native mitral valve disease with severe mitral annular calcification: results from the first multicenter global registry. JACC Cardiovasc Interv2016; 9: 1361–1371.
5.
LeeRFukuharaSGeorgeI,et al.Mitral valve replacement with a transcatheter valve in the setting of severe mitral annular calcification. J Thorac Cardiovasc Surg2016; 151: e47–e49.
6.
IshidaMTodaKNakamuraT, et al.Reinforced mitral valve replacement using a xenopericardium collared prosthetic valve for a heavily calcified or disrupted mitral annulus: a simple “dumpling technique”. Surg Today2017; 47: 895–898.
